Results of open surgery or endoscopic choledocholithotomy in the treatment of hepatolithiasis and risk factors
10.3760/cma.j.issn.1007-631X.2012.10.002
- VernacularTitle:肝内胆管结石手术与内镜取石的疗效对比与危险因素分析
- Author:
Chenglin ZHU
;
Qiang HUANG
;
Chenhai LIU
;
Fang XIE
;
Qian YAO
- Publication Type:Journal Article
- Keywords:
Cholelithiasis;
Hepatectomy;
Endoscopy,digestive system
- From:
Chinese Journal of General Surgery
2012;27(10):781-785
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the short and long-term outcomes and risk factors after open surgery or and endoscopic hepatolithotomy for hepatolithiasis. Methods A retrospective study was made on cases of hepatolithiasis who underwent hepatolithotomy by open surgery or endoscopically from Jan 2001 to Dec 2008.Of 254 patients,189 were followed-up including 127 after open surgery and 62 endoscopically.The univariate and multivariate analyses were performed to determine the risk factors. Results Complete stone clearance was achieved in 85.0 ％ ( 108/127 ) of open surgery including hepatecomy,61.3 ％ ( 38/62 )of endoscopic treatment.After a median follow-up period of 6.0 years (2.5 to 10.5 years),stone recurred in 32.8％ (62/189) of patients,biliary cirrhosis in 7.4％ ( 14/189),cholangiocarcinoma in 7(3.7％ ),all cancer cases were dead with a mortality rate of 7(3.7％ ).Bile duct stricture (OR:7.522,95％ CI:2.642 -21.415),stones in both lobes (OR:11.630,95％ CI:3.989 -33.912),and endoscopic treatment ( OR:21.374,95％ CI:6.713 - 68.056 ) were independent risk factors ( P ＜ 0.05 ) for incomplete stone clearance by unconditional Logistic regression analysis.In addition,recurrent stones and/or cholangitis were associated with residual stones ( OR:3.059,95％ CI:1.307 - 7.159),stricture ( OR:3.702,95％ CI:1.567-8.745) and endoscopic therapy (OR:4.841,95％ CI:1.946 - 12.043) (P ＜ 0.05).Conclusions Stricture,stone in both lobes and endoscope therapy were independent risk factors for residual stones; Residual stones,bile duct stricture and endoscope therapy were independent risk factors for recurrent stones and/or cholangitis.
